BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 24283067)

  • 1. [Polycystic ovarian syndrome and obstructive sleep apnea].
    Gateva A; Kamenov Z; Mondeshki Ts; Bilyukov R; Georgiev O
    Akush Ginekol (Sofiia); 2013; 52(3):63-8. PubMed ID: 24283067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polycystic ovary syndrome is associated with obstructive sleep apnea and daytime sleepiness: role of insulin resistance.
    Vgontzas AN; Legro RS; Bixler EO; Grayev A; Kales A; Chrousos GP
    J Clin Endocrinol Metab; 2001 Feb; 86(2):517-20. PubMed ID: 11158002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comorbidities in polycystic ovary syndrome: their relationship to insulin resistance.
    Bethea SW; Nestler JE
    Panminerva Med; 2008 Dec; 50(4):295-304. PubMed ID: 19078870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased prevalence of obstructive sleep apnea syndrome in obese women with polycystic ovary syndrome.
    Fogel RB; Malhotra A; Pillar G; Pittman SD; Dunaif A; White DP
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1175-80. PubMed ID: 11238505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sleep apnea is a manifestation of the metabolic syndrome.
    Vgontzas AN; Bixler EO; Chrousos GP
    Sleep Med Rev; 2005 Jun; 9(3):211-24. PubMed ID: 15893251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The sympathetic nervous system in polycystic ovary syndrome: a novel therapeutic target?
    Lansdown A; Rees DA
    Clin Endocrinol (Oxf); 2012 Dec; 77(6):791-801. PubMed ID: 22882204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the proportion and clinical characteristics of obstructive sleep apnea in women with polycystic ovary syndrome.
    Yang R; Gao C; Yan Y; Huang Y; Wang J; Zhang C; Ma X; Li N; Du X; Zhang L; Wang Y; Li R; Qiao J
    Sleep Breath; 2022 Mar; 26(1):497-503. PubMed ID: 34013438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic dysfunction in pcos: Relationship to obstructive sleep apnea.
    Ehrmann DA
    Steroids; 2012 Mar; 77(4):290-4. PubMed ID: 22178788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obstructive sleep apnea and metabolic dysfunction in polycystic ovary syndrome.
    Nitsche K; Ehrmann DA
    Best Pract Res Clin Endocrinol Metab; 2010 Oct; 24(5):717-30. PubMed ID: 21112021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiometabolic features of polycystic ovary syndrome.
    Hoffman LK; Ehrmann DA
    Nat Clin Pract Endocrinol Metab; 2008 Apr; 4(4):215-22. PubMed ID: 18250636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of obstructive sleep apnea on insulin resistance and glucose tolerance in women with polycystic ovary syndrome.
    Tasali E; Van Cauter E; Hoffman L; Ehrmann DA
    J Clin Endocrinol Metab; 2008 Oct; 93(10):3878-84. PubMed ID: 18647805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type 2 diabetes and the polycystic ovary syndrome.
    Pelusi B; Gambineri A; Pasquali R
    Minerva Ginecol; 2004 Feb; 56(1):41-51. PubMed ID: 14973409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Multisystemic involvement in obstructive sleep apnea].
    Labarca G; Cruz N R; Descalzi F
    Rev Med Chil; 2014 Jun; 142(6):748-57. PubMed ID: 25327320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular risk and insulin resistance in patients with obstructive sleep apnea.
    Tkacova R; Dorkova Z; Molcanyiova A; Radikova Z; Klimes I; Tkac I
    Med Sci Monit; 2008 Sep; 14(9):CR438-44. PubMed ID: 18758413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Markers of visceral obesity and cardiovascular risk in patients with polycystic ovarian syndrome.
    Gateva AT; Kamenov ZA
    Eur J Obstet Gynecol Reprod Biol; 2012 Oct; 164(2):161-6. PubMed ID: 22727921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obstructive sleep apnoea and polycystic ovary syndrome: A comprehensive review of clinical interactions and underlying pathophysiology.
    Kahal H; Kyrou I; Tahrani AA; Randeva HS
    Clin Endocrinol (Oxf); 2017 Oct; 87(4):313-319. PubMed ID: 28640938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic and endocrine status associate with obstructive sleep apnea risk among patients with polycystic ovary syndrome.
    Christ JP; Shinkai K; Corley J; Pasch L; Cedars MI; Huddleston HG
    J Clin Sleep Med; 2024 Jun; 20(6):871-877. PubMed ID: 38217476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic and cardiovascular consequences of polycystic ovary syndrome.
    Orio F; Vuolo L; Palomba S; Lombardi G; Colao A
    Minerva Ginecol; 2008 Feb; 60(1):39-51. PubMed ID: 18277351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of polysomnographic variables between adolescents with polycystic ovarian syndrome with and without the metabolic syndrome.
    de Sousa G; Schlüter B; Menke T; Trowitzsch E; Andler W; Reinehr T
    Metab Syndr Relat Disord; 2011 Jun; 9(3):191-6. PubMed ID: 21352077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polycystic ovaries - beyond menopause.
    Shah D; Bansal S
    Climacteric; 2014 Apr; 17(2):109-15. PubMed ID: 23895379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.